199 related articles for article (PubMed ID: 27105909)
21. Polycystic ovary syndrome influences the level of serum amyloid A and activity of phospholipid transfer protein in HDL₂ and HDL₃.
Gidwani S; Phelan N; McGill J; McGowan A; O'Connor A; Young IS; Gibney J; McEneny J
Hum Reprod; 2014 Jul; 29(7):1518-25. PubMed ID: 24842896
[TBL] [Abstract][Full Text] [Related]
22. High-density lipoprotein loses its anti-inflammatory capacity by accumulation of pro-inflammatory-serum amyloid A.
Tölle M; Huang T; Schuchardt M; Jankowski V; Prüfer N; Jankowski J; Tietge UJ; Zidek W; van der Giet M
Cardiovasc Res; 2012 Apr; 94(1):154-62. PubMed ID: 22328092
[TBL] [Abstract][Full Text] [Related]
23. Heparan sulfate dissociates serum amyloid A (SAA) from acute-phase high-density lipoprotein, promoting SAA aggregation.
Noborn F; Ancsin JB; Ubhayasekera W; Kisilevsky R; Li JP
J Biol Chem; 2012 Jul; 287(30):25669-77. PubMed ID: 22654109
[TBL] [Abstract][Full Text] [Related]
24. Serum amyloid A facilitates the binding of high-density lipoprotein from mice injected with lipopolysaccharide to vascular proteoglycans.
Chiba T; Chang MY; Wang S; Wight TN; McMillen TS; Oram JF; Vaisar T; Heinecke JW; De Beer FC; De Beer MC; Chait A
Arterioscler Thromb Vasc Biol; 2011 Jun; 31(6):1326-32. PubMed ID: 21474830
[TBL] [Abstract][Full Text] [Related]
25. Serum amyloid A is not incorporated into HDL during HDL biogenesis.
Ji A; Wang X; Noffsinger VP; Jennings D; de Beer MC; de Beer FC; Tannock LR; Webb NR
J Lipid Res; 2020 Mar; 61(3):328-337. PubMed ID: 31915139
[TBL] [Abstract][Full Text] [Related]
26. The relationship between serum amyloid A and apolipoprotein A-I in high-density lipoprotein isolated from patients with coronary heart disease.
Wang DX; Liu H; Yan LR; Zhang YP; Guan XY; Xu ZM; Jia YH; Li YS
Chin Med J (Engl); 2013; 126(19):3656-61. PubMed ID: 24112159
[TBL] [Abstract][Full Text] [Related]
27. Apolipoprotein A-II induces acute-phase response associated AA amyloidosis in mice through conformational changes of plasma lipoprotein structure.
Yang M; Liu Y; Dai J; Li L; Ding X; Xu Z; Mori M; Miyahara H; Sawashita J; Higuchi K
Sci Rep; 2018 Apr; 8(1):5620. PubMed ID: 29618729
[TBL] [Abstract][Full Text] [Related]
28. Serum amyloid A self-assembles with phospholipids to form stable protein-rich nanoparticles with a distinct structure: A hypothetical function of SAA as a "molecular mop" in immune response.
Frame NM; Jayaraman S; Gantz DL; Gursky O
J Struct Biol; 2017 Dec; 200(3):293-302. PubMed ID: 28645735
[TBL] [Abstract][Full Text] [Related]
29. High-density lipoprotein as carrier for amyloid-related protein SAA in rabbit serum.
Skogen B; Børresen AL; Natvig JB; Berg K; Michaelsen TE
Scand J Immunol; 1979; 10(1):39-45. PubMed ID: 224449
[TBL] [Abstract][Full Text] [Related]
30. Serum amyloid A changes high density lipoprotein's cellular affinity. A clue to serum amyloid A's principal function.
Kisilevsky R; Subrahmanyan L
Lab Invest; 1992 Jun; 66(6):778-85. PubMed ID: 1602745
[TBL] [Abstract][Full Text] [Related]
31. Acute-phase serum amyloid A: perspectives on its physiological and pathological roles.
Kisilevsky R; Manley PN
Amyloid; 2012 Mar; 19(1):5-14. PubMed ID: 22320226
[TBL] [Abstract][Full Text] [Related]
32. Serum amyloid A and high density lipoproteins during the acute phase response.
Bausserman LL; Bernier DN; McAdam KP; Herbert PN
Eur J Clin Invest; 1988 Dec; 18(6):619-26. PubMed ID: 3147188
[TBL] [Abstract][Full Text] [Related]
33. Marked Changes in Serum Amyloid A Distribution and High-Density Lipoprotein Structure during Acute Inflammation.
Shimano S; Ohkawa R; Nambu M; Sasaoka M; Yamazaki A; Fujii Y; Horiuchi Y; Lai SJ; Kameda T; Ichimura N; Fujita K; Tohda S; Tozuka M
Biomed Res Int; 2021; 2021():9241259. PubMed ID: 33575357
[TBL] [Abstract][Full Text] [Related]
34. High-density lipoprotein has different binding capacity for different apoproteins. The amyloidogenic apoproteins are easier to displace from high-density lipoprotein.
Husebekk A; Skogen B; Husby G
Scand J Immunol; 1988 Dec; 28(6):653-8. PubMed ID: 3232030
[TBL] [Abstract][Full Text] [Related]
35. [Serum amyloid protein A (SAA) and HDL. Clinical implication and surgical resuscitation].
Bienvenu J; Deshaires P; Bernon H; Armanet P; Peristeris P; Lepape A; Perdrix JP
Ann Biol Clin (Paris); 1988; 46(5):343-6. PubMed ID: 3138928
[TBL] [Abstract][Full Text] [Related]
36. Changes in high density lipoprotein content following endotoxin administration in the mouse. Formation of serum amyloid protein-rich subfractions.
Hoffman JS; Benditt EP
J Biol Chem; 1982 Sep; 257(17):10510-7. PubMed ID: 7107614
[TBL] [Abstract][Full Text] [Related]
37. Serum amyloid A receptor blockade and incorporation into high-density lipoprotein modulates its pro-inflammatory and pro-thrombotic activities on vascular endothelial cells.
Chami B; Barrie N; Cai X; Wang X; Paul M; Morton-Chandra R; Sharland A; Dennis JM; Freedman SB; Witting PK
Int J Mol Sci; 2015 May; 16(5):11101-24. PubMed ID: 25988387
[TBL] [Abstract][Full Text] [Related]
38. Why working with porcine circulating serum amyloid A is a pig of a job.
Soler L; Molenaar A; Merola N; Eckersall PD; Gutiérrez A; Cerón JJ; Mulero V; Niewold TA
J Theor Biol; 2013 Jan; 317():119-25. PubMed ID: 23073471
[TBL] [Abstract][Full Text] [Related]
39. Acute-phase-HDL remodeling by heparan sulfate generates a novel lipoprotein with exceptional cholesterol efflux activity from macrophages.
Tam SP; Kisilevsky R; Ancsin JB
PLoS One; 2008; 3(12):e3867. PubMed ID: 19057652
[TBL] [Abstract][Full Text] [Related]
40. Serum amyloid A (SAA): influence on HDL-mediated cellular cholesterol efflux.
Banka CL; Yuan T; de Beer MC; Kindy M; Curtiss LK; de Beer FC
J Lipid Res; 1995 May; 36(5):1058-65. PubMed ID: 7658153
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
